Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cellegy Pharmaceuticals

Cellegy Pharmaceuticals, Inc. is a specialty biopharmaceutical company engaged in the development and commercialization of prescription drugs including topical treatments for anal fissures and hemorrhoids and hormone replacement therapy for men and women. We recently expanded our research to include other potential products based on nitric oxide pharmacology through the acquisition of Vaxis Therapeutics, now Cellegy Canada Inc.


Contact Details:
349 Oyster Point Boulevard, Suite 200
South San Francisco
CA
94080
United States of America
Tel:650 616 2200
Fax:650 616 2222
Email:
WWW:

www.cellegy.com/




Loading...

Press Releases on Cellegy Pharmaceuticals:

BioPortfolio Logo
Cellegy and Adamis Stockholders Approve Merger Transaction and Related Proposals 24th March, 2009 Cellegy Pharmaceuticals, Inc.
Reverse Split Ratio of Outstanding Cellegy Common Stock Expected to be Approximately 1: 9.929060 BOYERTOWN, Pa., March 24 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. (OTC Bulletin Board:
Dow Pharmaceutical Sciences Announces Recent Hires 1st January, 1970 Dow Pharma
  Dow Pharmaceutical Sciences Announces Recent Hires  Petaluma, California (Feb 19, 2003) – Dow Pharmaceutical Sciences, a contract development

BioNews Results for Cellegy Pharmaceuticals:

Cellegy Pharmaceuticals Inc.-Deals & Alliances Report - research report released
PR inside:  Oct 28 2009 6:28PM Matching: cellegy pharmaceuticals

Cellegy Pharmaceuticals Clinical Trials:

Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis

Cellegy Pharmaceuticals Patents:

US Patent No.Title
7157097 Penetration enhancing and irritation reducing systems
6395736 Compositions and methods for the treatment of anorectal disorders
6319913 Penetration enhancing and irritation reducing systems
6190894 Method and compositions for disrupting the epithelial barrier function
6071543 Pyridine-thiols reverse mucocutaneous aging

View more Cellegy Pharmaceuticals patents.

Cellegy Pharmaceuticals (CLGY) Financial information Links from Barchart

CLGY Quote from from Barchart.com
CLGY Chart from from Barchart.com
CLGY Profile from from Barchart.com
CLGY Opinion from from Barchart.com

View more Cellegy Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 446 times since April 2007, the link to the organisation's website has been followed 86 times

Recent Search Terms used to find this page: CELLEGY PHARMACEUTICALS INC boyerton pa | .

Search for more companies in South San Francisco

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cellegy Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.